default author photo

Yanping Hu

University of Texas Medical Branch-Galveston - Department of Biochemistry and Molecular Biology

SCHOLARLY PAPERS

1

DOWNLOADS

257

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

A Phase 2/3 Trial to Investigate the Safety and Immunogenicity of Monovalent Omicron Jn.1-Adapted Bnt162b2 Covid-19 Vaccine in Adults ≥18 Years Old

Number of pages: 27 Posted: 25 Oct 2024
Oyeniyi Diya, Juleen Gayed, Francine S. Lowry, Hua Ma, Vishva Bangad, Federico Mensa, Jing Zou, Xuping Xie, Yanping Hu, Mark Cutler, Todd Belanger, David Cooper, Xia Xu, Kenneth Koury, Özlem Türeci, Ugur Sahin, Kena A. Swanson, Kayvon Modjarrad, Annaliesa S. Anderson, Alejandra Gurtman and Nicholas Kitchin
Pfizer Vaccine Clinical Research and Development, Pfizer Vaccine Clinical Research and Development, Pfizer Inc Pennsylvania, Pfizer Inc Pennsylvania, Pfizer Inc Pennsylvania, BioNTech (Germany), University of Texas Medical Branch-Galveston - Department of Biochemistry and Molecular Biology, University of Texas Medical Branch-Galveston - Department of Biochemistry and Molecular Biology, University of Texas Medical Branch-Galveston - Department of Biochemistry and Molecular Biology, Pfizer Worldwide Research and Development, Pfizer Worldwide Research and Development, Pfizer Worldwide Research and Development, Pfizer Worldwide Research and Development, Pfizer Worldwide Research and Development, BioNTech (Germany), BioNTech (Germany), Pfizer Worldwide Research and Development, Pfizer Worldwide Research and Development, Pfizer Worldwide Research and Development, Pfizer Worldwide Research and Development and Pfizer Vaccine Clinical Research and Development
Downloads 257 (296,486)

Abstract:

Loading...

BNT162b2, booster, COVID-19, Omicron JN.1, SARS-CoV-2 vaccine, variant-adapted